|
1. |
Intravenous magnesium does not influence the activity of the coagulation cascade |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 223-228
H. Ravn,
J. Lassen,
N. Bergenhem,
A. Kristensen,
Preview
|
PDF (136KB)
|
|
摘要:
Experimental arterial thrombus formation is reduced during intravenous magnesium infusion. It is well documented that magnesium reduces platelet reactivity, but the antithrombotic effect could also originate from anticoagulant properties or increased fibrinolysis. We therefore evaluated the effect of intravenous magnesium on prothrombin fragment 1 + 2 (F1 + 2), thrombin–antithrombin III complex (TAT) concentrations, and fibrin degradation products (FbDP) in a randomized, cross-over study in 14 healthy volunteers. Citrated blood samples were collected at 0, 30, and 180 min. An additionalin vitrostudy on magnesium's effect on the activity of different coagulation factors was carried out. A transient increase was seen in F1 + 2and TAT after 30 min but without any significant difference between the placebo and magnesium period. FbDP did not change significantly between the two treatments. Increasing concentrations of magnesium dose-dependently decreased binding of activated factor X to activated factor VII (FVIIa), but the decrease was slight and probably without any significance for coagulation at the concentrations tested. No effect was observed on the activity of FVIIa or activated factor VIII. In conclusion, no significant differences were observed on markers of coagulation or fibrinolytic activity during intravenous magnesium infusion. These results indicate that the observed antithrombotic effect of magnesium is more likely to arise from the previously observed platelet inhibition.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
2. |
Stability of coagulation proteins in frozen plasma |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 229-236
B. Woodhams,
O. Girardot,
M. Blanco,
G. Colesse,
Y. Gourmelin,
Preview
|
PDF (180KB)
|
|
摘要:
This study reports on the frozen stability of all commonly measured coagulation proteins in normal citrated plasma: activated partial thromboplastin time, prothrombin time (%), thrombin time and fibrinogen (Clauss); clotting assays for factors II, V, VII, VIII, IX, X, XI and XII; functional assays for protein C (clotting), protein S (clotting), antithrombin (chromogenic) and plasminogen (chromogenic); and immunological assays for von Willebrand factor and D-dimer. All these factors listed are stable for up to 3 months if frozen at −24°C or lower. At −74°C, all these factors (allowing for 10% variation) were stable for at least 18 months, most were stable for 24 months. The number of proteins showing > 5% variation over baseline after 6 months storage indicates that some decay does occur even at −74°C. There was no clear advantage in snap freezing at −74°C and then storing at −24°C over both freezing and storing at −24°C; therefore, the freezing process itself is not responsible for the loss of stability. The best stability, especially at −24°C, was obtained when small samples (1 ml) were stored in screw-cap tubes with a minimum dead space. The decrease in stability of the coagulation proteins directly correlates with the effect of temperature and time.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
3. |
Location of the platelet binding site in zymogen coagulation factor IX |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 237-243
L. Melton,
T. Li,
D. Stafford,
D. Gabriel,
Preview
|
PDF (208KB)
|
|
摘要:
The assembly of the tenase complex on the surface of the platelet is an essential step in maintaining normal hemostasis as evidenced by the serious hemorrhagic diathesis associated with either factor IX (FIX) or factor VIII deficiencies. Understanding the regions and or residues of FIX crucial for proper binding to platelets has important clinical implications. The ability of FIX to bind activated platelets in the presence of 4 mmol/l CaCl2was examined using electrophoretic light-scattering experiments. Wild-type FIX binds to activated platelets with dissociation constantKd= 7.9 nmol/l. Activated FIX binds to activated platelets withKd= 2 nmol/l. Activated factor VII does not bind activated platelets at physiological concentrations. The Gla domain of FIX is important for the binding of FIX to activated platelets since a chimera with a factor VII (FVII) template and FIX Gla [FVII(FIXGla)] hasKd= 9.6 nmol/l, and a chimera with a FVII template and FIX Gla, A and the first epidermal growth factor domain (EGF1) [FVII(FIXGla,A,EGF1)] hasKd= 9.7 nmol/l, but a chimera with a FIX template and a FVII Gla [FIX(FVIIGla)] does not bind activated platelets. Altering the fifth residue of FIX from a lysine to an alanine (Lys5←Ala) abolishes the mutant from binding to collagen but does not affect FIX binding to the activated platelet (Kd= 9.8 nmol/l). Point mutations involved with residues 4 and 5 (Gly4←Phe and Lys5←no residue), residue 9 (Phe9←Ala), residue 10 (Val10←Lys) and residues 9–11 (Phe9←Met, Val10←Lys, Glu11←Lys) do not bind to activated platelets.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
4. |
Fluorescent multiplex polymerase chain reaction analysis of four genes associated with inpaired fibrinolysis and myocardial infarction |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 245-251
M. Renshaw,
D. Ellingsen,
B. Costner,
J. Benson,
J. Heit,
W. Hooper,
Preview
|
PDF (399KB)
|
|
摘要:
Multiplex polymerase chain reaction (PCR) allows for the simultaneous amplification of several genes, thereby optimizing the use of reagents and decreasing personnel time. Multiplex PCR was used to amplify four genes in one PCR reaction, demonstrating the advantage of multiplex PCR for our study since it allowed us to amplify four separate genes using only 1 μl DNA, thus maximizing the use of study DNA. As compared with conventional multiplex PCR analysis with ethidium bromide, incorporating fluorescence-labeled primers into multiplex PCR reactions facilitated accurate, simultaneous analysis of many DNA fragments within one base discrimination. We have used this fluorescence methodology to analyze polymorphisms associated with either impaired fibrinolysis or myocardial infarction. These include the angiotensin converting enzyme insertion/deletion (I/D) polymorphism in intron 16 of the DCP1 gene, the Alu I/D polymorphism of the tissue plasminogen activator-25 locus in intron 8, the plasminogen activator inhibitor 4G/5G repeat polymorphism, and the variable number tandem repeat of the endothelial cell nitric oxide synthase gene, all characterized by an insertion, deletion, or repeat. The amplified products were diluted 1 : 60 and analyzed on the ABI PRISM®310 Genetic Analyzer using GeneScan®software. With this method, we were able to amplify four genes using 75% less reagents and personnel time, thus demonstrating the benefit of multiplex PCR and fluorescence technology.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
5. |
In vitrointeraction of C1-inhibitor with thrombin |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 253-260
M. Cugno,
I. Bos,
Y. Lubbers,
C. Hack,
A. Agostoni,
Preview
|
PDF (187KB)
|
|
摘要:
Previous observations of increased generation of thrombin during acute attacks of angioedema in plasma of patients with C1-inhibitor (C1-INH) deficiency prompted us to evaluate the interaction of C1-INH with thrombin in both purified systems and human plasma. For this purpose, we used several methods: (1) sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting analysis; (2) enzyme-linked immunosorbent assays to measure complexes between C1-INH and thrombin and inactivated C1-INH; and (3) kinetic studies using a chromogenic assay. We found that the interaction of purified C1-INH with thrombin is associated with the formation of bimolecular complexes of molecular weight (Mr) 130 000 and 120 000 as well as with the appearance of a cleaved form of C1-INH ofMr97 000. The kinetic studies of inhibition of thrombin by C1-INH showed an average second-order rate constant of 19/s per mol/l, which was significantly increased in the presence of heparin. The addition of thrombin to human plasma was not associated with detectable C1-INH–thrombin complex formation or with cleavage of C1-INH. In conclusion, our data demonstrate that C1-INH upon interaction with thrombin, in part, forms enzyme–inhibitor complexes and, in part, is cleaved. The low second-order rate constant and the lack of a significant interaction in plasma suggest that the inhibition of thrombin by C1-INH has a minor role in circulating blood; however, its role might be important at the endothelial surface, where high concentrations of glycosaminoglycans occur.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
6. |
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 261-267
L. Olivotti,
P. Spallarossa,
A. Piana,
A. Iannone,
P. Rossettin,
G. Ghigliotti,
U. Armani,
A. Barsotti,
C. Brunelli,
Preview
|
PDF (160KB)
|
|
摘要:
Procoagulant and fibrinolytic disturbances are described in patients with acute coronary syndromes (ACS), but whether defective maximal tissue plasminogen activator (t-PA) release from the endothelium is also present is still controversial. Previous studies did not take into consideration the contribution of heparin, which strongly affects fibrinolysis. Accordingly, in this study, we measured maximal t-PA release in patients with ACS before, during, and after heparin treatment. Maximal t-PA release was measured by the venous occlusion test in 38 hospitalized patients with confirmed ACS (18 acute myocardial infarctions and 20 unstable anginas) before starting heparin, during heparin treatment, and 4 and 12 h after discontinuation. Plasma plasminogen activator inhibitor type 1 (PAI-1), D-dimer and prothrombin fragment F1 + 2 were also measured. Eighteen age-matched subjects with no evidence of coronary disease were used as controls. At admission, patients showed significantly higher plasma levels of t-PA, PAI-1, and F1 + 2 than controls. Before heparin, maximal t-PA release was similar in patients and controls. Heparin treatment was associated with a significant increase of plasma t-PA, while it did not affect maximal t-PA release. Coagulative and fibrinolytic disturbances are present in patients with ACS, but these do not include maximal t-PA release. Among our patients, maximal t-PA release appears stable over time and is not affected by heparin treatment.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
7. |
Changes in the extrinsic and intrinsic coagulation pathways in humans after decompression following saturation diving |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 269-274
R. Olszański,
P. Radziwon,
Z. Baj,
P. Kaczmarek,
J. Giedrojć,
M. Galar,
J. Kuuloczko,
Preview
|
PDF (143KB)
|
|
摘要:
We have investigated the effect of simulated saturation diving on the activation of intrinsic and extrinsic coagulation pathways. Thirty-one male divers divided into two groups were tested in decompression habitat LSH-200. The first group of 16 divers was subjected to hyperbaric exposure at pressure of 180 kPa with air as a breathing mixture, and the second group of 15 divers, exposed to a pressure of 400 kPa with a heliox breathing mixture (helium–oxygen mixture: pO2, 40 kPa; pN2, 40 kPa; pHe, 420 kPa). The concentrations of tissue factor, tissue factor pathway inhibitor, factors XII, X, VII, and I, prothrombin fragment F1 + 2, and thrombin–antithrombin complex as well as platelet count, prothrombin time, activated partial thromboplastin time, plasmin–antiplasmin complex (PAP) and D-dimers were measured. We did not detect activation of the extrinsic coagulation pathway after decompression. There was a statistically significant decrease in platelet counts and factor I, XII and X concentrations after air-diving, and a potent and statistically significant increase of PAP concentration in both groups of divers. We suggest that saturated air or heliox diving followed by decompression have little if any effect on thrombin generation. Saturated air diving, however, may induce a decrease in platelet count and factor XII concentration. The observed elevation of PAP concentrations in both groups of divers suggests possible activation of fibrinolysis. The exact effect of diving and decompression on fibrinolytic system has to be further investigated.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
8. |
Depressed plasma activity of plasminogen or α2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 275-281
H. Asakura,
Y. Ontachi,
T. Mizutani,
M. Kato,
T. Ito,
M. Saito,
E. Morishita,
M. Yamazaki,
Y. Suga,
K. Miyamoto,
S. Nakao,
Preview
|
PDF (171KB)
|
|
摘要:
We have attempted to determine whether depressed plasma plasminogen and α2 plasmin inhibitor (or α2 antiplasmin) activity is, as a result of consumption coagulopathy, a specific finding of disseminated intravascular coagulation (DIC) in septic patients. The hemostatic parameters of 139 septic patients (68 with DIC and 71 without DIC) were analyzed. Among the group as a whole, plasma activities of plasminogen and α2 plasmin inhibitor were significantly depressed in septic patients with DIC relative to those without DIC (P< 0.01 andP< 0.05, respectively). Notably, a significant correlation was observed between plasma levels of albumin and plasminogen activity, as well as between plasma levels of albumin and α2 plasmin inhibitor activity both in septic patients with DIC and those without DIC. However, no significant correlation was observed between plasma levels of plasmin–α2 plasmin inhibitor complex (PIC) and plasminogen activity, nor between PIC and α2 plasmin inhibitor activity either in septic patients with DIC or those without DIC. We concluded that depressed activity of plasminogen or α2 plasmin inhibitor is not as a result of consumption coagulopathy, but rather a result of low synthetic function of the liver in septic patients with DIC.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
9. |
Thrombogenic alleles,Escherichia coliO157:H7 infections, and hemolytic uremic syndrome |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 283-288
J. Sprouse,
C. Wong,
W. Chandler,
G. Williams,
S. Watkins,
P. Tarr,
Preview
|
PDF (127KB)
|
|
摘要:
Hemolytic uremic syndrome (HUS) of childhood most commonly follows gastrointestinal infection withEscherichia coliO157:H7. This pathogen elaborates Shiga toxins that are believed to cause microvascular injury and to trigger a thrombogenic response. The exact mechanisms leading to variable disease manifestations are unknown. Allelic variation in genes encoding selected coagulation factors and inhibitors of fibrinolysis were examined to determine whether or not a causal relationship exists between hypercoagulability and the development of HUS. No correlation between the thrombogenic factor V (G1691A), factor II (G20210A), methylenetetrahydrofolate reductase (C677T), or the plasminogen activator inhibitor (PAI)-1 promotor (4G/5G) genotypes and the risk of infection withE. coliO157:H7, or the risk of development of HUS among infected patients, was found. Serum PAI-1 levels did not correlate with the PAI-1 genotype. We conclude that the alleles studied are not major risk factors for the acquisition ofE. coliO157:H7 infection, or ofE. coliO157:H7-related HUS.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
10. |
In vitrofactor XI activation mechanism according to an optimized model of activated partial thromboplastin time test |
|
Blood Coagulation and Fibrinolysis,
Volume 12,
Issue 4,
2001,
Page 289-299
A. Kramoroff,
J. Nigretto,
Preview
|
PDF (229KB)
|
|
摘要:
Whether thein vitroactivation of factor XI in plasma is mediated by thrombin or by auto-activation remains a controversial question. In this context, we have simulated theoretical activated partial thromboplastin time (aPTT) by means of a program based on a body of 22 essential elementary reactions implemented with rate constants quoted in current literature. To meet self-consistency in input data issued from varying sources, the results were optimized using the simplex treatment. The performance of the model was systematically evaluated considering the extent of the deviations observed between predicted aPTT and laboratory measurements conducted on normal and factor VIII, IX, XI and XII single-factor deficient plasma. The influence of the auto-activation or thrombin-mediated activation of factor XI on these aPTTs was tested separately after insertion of these reactions in the model. According to the best fits, a mechanism accounting for an auto-activation reaction of activated factor XI rather than a positive feedback reaction mediated by thrombin seemed more likely. Based on this conclusion, a chart of self-consistent rate constant values accounting for the intrinsic pathway of coagulation under static conditions is proposed.
ISSN:0957-5235
出版商:OVID
年代:2001
数据来源: OVID
|
|